PCR was performed using BCR–ABL gene-specific primers to determine whether the genetic change was identical (or similar) to the Ph+ chromosome in human CML (Chereda and Melo, 2015). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.